Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Tr (Q34668487)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Tr |
scientific article |
Statements
1 reference
Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Tr (English)
1 reference
Robert M Califf
1 reference
Kenneth W Mahaffey
1 reference
Jonathan P Piccini
1 reference
Jonathan L Halperin
1 reference
Günter Breithardt
1 reference
Yuliya Lokhnygina
1 reference
Daniel E Singer
1 reference
Manesh R Patel
1 reference
Keith A A Fox
1 reference
Christopher C Nessel
1 reference
ROCKET AF Steering Committee and Investigators
1 reference
Susanna R Stevens
1 reference
Jeffrey B Washam
1 reference
Identifiers
1 reference